- Home
- ARTV vs INGN Comparison
ARTV vs INGN Comparison
Compare ARTV & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTV
- INGN
- Stock Information
- Founded
- ARTV 2019
- INGN 2001
- Country
- ARTV United States
- INGN United States
- Employees
- ARTV N/A
- INGN N/A
- Industry
- ARTV
- INGN Industrial Specialties
- Sector
- ARTV
- INGN Health Care
- Exchange
- ARTV NYSE
- INGN Nasdaq
- Market Cap
- ARTV 232.8M
- INGN 260.2M
- IPO Year
- ARTV 2024
- INGN 2014
- Fundamental
- Price
- ARTV $11.79
- INGN $10.76
- Analyst Decision
- ARTV Strong Buy
- INGN Hold
- Analyst Count
- ARTV 5
- INGN 4
- Target Price
- ARTV $21.25
- INGN $7.00
- AVG Volume (30 Days)
- ARTV 79.3K
- INGN 155.9K
- Earning Date
- ARTV 08-29-2024
- INGN 11-05-2024
- Dividend Yield
- ARTV N/A
- INGN N/A
- EPS Growth
- ARTV N/A
- INGN N/A
- EPS
- ARTV N/A
- INGN N/A
- Revenue
- ARTV $29,256,000.00
- INGN $326,653,000.00
- Revenue This Year
- ARTV N/A
- INGN $5.76
- Revenue Next Year
- ARTV N/A
- INGN $4.10
- P/E Ratio
- ARTV N/A
- INGN N/A
- Revenue Growth
- ARTV 493.31
- INGN N/A
- 52 Week Low
- ARTV $9.71
- INGN $4.13
- 52 Week High
- ARTV $16.00
- INGN $13.33
- Technical
- Relative Strength Index (RSI)
- ARTV N/A
- INGN 40.05
- Support Level
- ARTV N/A
- INGN $10.80
- Resistance Level
- ARTV N/A
- INGN $11.68
- Average True Range (ATR)
- ARTV 0.00
- INGN 0.52
- MACD
- ARTV 0.00
- INGN -0.23
- Stochastic Oscillator
- ARTV 0.00
- INGN 4.51
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.